Social Media Influencers Driving Parallel Trade for Unlicensed Slimming Drug
An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Treatment Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in users injecting products of unknown origin.
Some experts stated the demand for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down problematic content and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of slimming results, glowing reviews and detailed guides for preparing or injecting at residence.
Within minutes of joining one group, a seller posted contact information, where most purchases take place. The vendor provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.
Item Information and Pricing
Inside these communities, posts show black plastic packages with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how much time a pen should last, vendors give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram stated it actively monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they cannot confirm. Although the science behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her staff has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject patients to possibly serious medical dangers”.